The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Pneumococcal resistance to antibiotics
Open accessAbstract
The geographic distribution of pneumococci resistant to one or more of the antibiotics penicillin, erythromycin, trimethoprim-sulfamethoxazole, and tetracycline appears to be expanding, and there exist foci of resistance to chloramphenicol and rifampin. Multiply resistant pneumococci are being encountered more commonly and are more often community acquired. Factors associated with infection caused by resistant pneumococci include young age, duration of hospitalization, infection with a pneumococcus of serogroup 6, 19, or 23 or serotype 14, and exposure to antibiotics to which the strain is resistant. At present, the most useful drugs for the management of resistant pneumococcal infections are cefotaxime, ceftriaxone, vancomycin, and rifampin. If the strains are susceptible, chloramphenicol may be useful as an alternative, less expensive agent. Appropriate interventions for the control of resistant pneumococcal outbreaks include investigation of the prevalence of resistant strains, isolation of patients, possible treatment of carriers, and reduction of usage of antibiotics to which the strain is resistant. The molecular mechanisms of penicillin resistance are related to the structure and function of penicillin-binding proteins, and the mechanisms of resistance to other agents involved in multiple resistance are being elucidated. Recognition is increasing of the standard screening procedure for penicillin resistance, using a 1-microgram oxacillin disk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, P., Trieu‐Cuot, P., & Courvalin, P. M. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.17.7047 · Cited by 142
The bacteriology of pneumococcal otitis media.
AUSTRIAN, R. C., Howie, V. M., & Ploussard, J. H. (1977) · PubMed · Cited by 92
Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era.
Mufson, M. A., Kruss, D. M., WASIL, R. E., et al. (1974) · PubMed · Cited by 70
An analysis of blood culture isolates from 7 South African teaching hospital centres.
van den Ende, J., & Rotter, M. (1986) · PubMed · Cited by 14
Cited by
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
Klugman, K. P., Madhi, S. A., Huebner, R. E., Kohberger, R., Mbelle, N., & Pierce, N. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035060 · Cited by 1,009
Self-citationHausdorff, W. P., Bryant, J., Paradiso, P. R., & Siber, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313608 · Cited by 866
Pallares, R., Liñares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F., Martin, R., & Gudiol, F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330802 · Cited by 773
Antimicrobial resistance in developing countries
Hart, C. A., & Kariuki, S. (1998) · BMJ · doi:10.1136/bmj.317.7159.647 · Cited by 745
The fluoroquinolone antibacterials: past, present and future perspectives
Appelbaum, P. C., & Hunter, P. A. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00192-8 · Cited by 629
Heffelfinger, J. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1399 · Cited by 610
Active Bacterial Core Surveillance of the Emerging Infections Program Network
Schuchat, A., Hilger, T., Zell, E., Farley, M. M., Reingold, A., Harrison, L., Lefkowitz, L., Danila, R., Stefonek, K., Barrett, N., et al. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010114 · Cited by 592
Emergence of Drug-Resistant Pneumococcal Infections in the United States
Breiman, R. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470035031 · Cited by 562
Doern, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L., & Brueggemann, A. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1721-1729.2001 · Cited by 538
McGee, L., McDougal, L., Zhou, J., Spratt, B. G., Tenover, F. C., George, R., Hakenbeck, R., Hryniewicz, W., Lefévre, J. C., Tomasz, A., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2565-2571.2001 · Cited by 518
Self-citationThe Prevalence of Drug-Resistant Streptococcus pneumoniae In Atlanta
Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A., Deaver, K. A., & Breiman, R. F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330803 · Cited by 503
Doern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482
Baraff, L. J., Bass, J. W., Fleisher, G. R., Klein, J. O., McCracken, G. H., Powell, K. R., & Schriger, D. L. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)80991-6 · Cited by 466
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
Pan, X. S., Ambler, J., Mehtar, S., & Fisher, L. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2321 · Cited by 437
Weiser, J. N., Austrian, R., Sreenivasan, P. K., & Masure, H. R. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2582-2589.1994 · Cited by 422
The Spread of Multiply Resistant Streptococcus pneumoniae at a Day Care Center in Ohio
Reichler, M. R., Allphin, A. A., Breiman, R. F., Schreiber, J. R., Arnold, J. E., McDougal, L. K., Facklam, R. R., Boxerbaum, B., May, D., Walton, R. O., et al. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.6.1346 · Cited by 376
Hoban, D. J., Doern, G. V., Fluit, A. C., Roussel‐Delvallez, M., & Jones, R. N. (2001) · Clinical Infectious Diseases · doi:10.1086/320181 · Cited by 375
Munoz-Almagro, C., Jordan, I., Gene, A., Latorre, C., Garcia-Garcia, J. J., & Pallares, R. (2008) · Clinical Infectious Diseases · doi:10.1086/524660 · Cited by 333
Liñares, J., Ardanuy, C., Pallares, R., & Fenoll, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03182.x · Cited by 323
New Mechanisms of Bacterial Resistance to Antimicrobial Agents
Epstein, F. H., Jacoby, G. A., & Archer, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102283240906 · Cited by 312
Kim, L., McGee, L., Tomczyk, S., & Beall, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-15 · Cited by 285
Resistance to Macrolides and Related Antibiotics in Streptococcus pneumoniae
Leclercq, R., & Courvalin, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2727-2734.2002 · Cited by 269
Marton, A., Gulyas, M., Munoz, R., & Tomasz, A. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.3.542 · Cited by 261
Interieukin-10 Impairs Host Defense in Murine Pneumococcal Pneumonia
van der Poll, T., Marchant, A., Keogh, C. V., Goldman, M., & Lowry, S. F. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.994 · Cited by 255
Berry, A. M., & Paton, J. C. (2000) · Infection and Immunity · doi:10.1128/iai.68.1.133-140.2000 · Cited by 255
White, A. R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh050 · Cited by 198
Jorgensen, J. H., Ferraro, M. J., McElmeel, M. L., Spargo, J., Swenson, J. M., & Tenover, F. C. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.1.159-163.1994 · Cited by 138
Acute Bacterial Meningitis in Infants and Children: Epidemiology and Management
Agrawal, S., & Nadel, S. (2011) · Pediatric Drugs · doi:10.2165/11593340-000000000-00000 · Cited by 99
PATHOGENS RESISTANT TO ANTIMICROBIAL AGENTS
Fraimow, H. S., & Abrutyn, E. (1995) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30683-8 · Cited by 37
Metadata
- Authors
- Klugman, K. P.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1990-04
- Volume
- 3
- Issue
- 2
- Pages
- 171-196
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W1897912436
- Cited by
- 799
- References
- 4
- FWCI
- 32.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.